The latest closing stock price for Aptevo Therapeutics as of June 03, 2025 is 4.97.
An investor who bought $1,000 worth of Aptevo Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -74.25% compound annual growth rate over 9 years.
The all-time high Aptevo Therapeutics stock closing price was 1000000.00 on July 20, 2016.
The Aptevo Therapeutics 52-week high stock price is 659.26, which is 13164.8% above the current share price.
The Aptevo Therapeutics 52-week low stock price is 4.30, which is 13.5% below the current share price.
The average Aptevo Therapeutics stock price for the last 52 weeks is 157.41.
An investor who bought $1,000 worth of Aptevo Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -74.25% compound annual growth rate over 9 years.
The all-time high Aptevo Therapeutics stock closing price was 1000000.00 on July 20, 2016.
The Aptevo Therapeutics 52-week high stock price is 659.26, which is 13164.8% above the current share price.
The Aptevo Therapeutics 52-week low stock price is 4.30, which is 13.5% below the current share price.
The average Aptevo Therapeutics stock price for the last 52 weeks is 157.41.